“…For gene delivery, the plasmid DNA is introduced into the target cells, and the genetic information is ultimately translated into the corresponding protein [18]. To achieve this, an efficient vector that possesses high transfection efficiency, biodegradability, targeting ability, DNA protecting ability, stimuli sensitivity, and low cytotoxicity for delivering a target gene to specific tissues or cells must be selected to cure both the genetic and acquired diseases of human [19]. Despite more gene transfection efficiency, viral vectors may pose a significant risk to patients, while nonviral carriers are inherently safer than viral carriers [20].…”